HEPATIC FIBROSIS
Clinical trials for HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hidden pain in liver patients: a new study reveals the truth
Knowledge-focused CompletedThis study looked at how often hospitalized patients with cirrhosis experience pain. Researchers asked 30 adults with cirrhosis about their pain during a single 15-45 minute visit. The goal was to find out how common pain is in this group, since it is often overlooked. This is an…
Matched conditions: HEPATIC FIBROSIS
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New liver drug tested for heart risks in healthy people
Knowledge-focused CompletedThis study checked whether a single dose of hydronidone, a drug being developed for liver scarring (hepatic fibrosis), affects the heart's electrical activity (QTc interval). 48 healthy Chinese adults took either a low, medium, or high dose of the drug or a placebo. The main goal…
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC